Porter A - Search Results

1

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.

Tester W, Porter A, Asbell S, Coughlin C, Heaney J, Krall J, Martz K, Venner P, Hammond E. Tester W, et al. Among authors: porter a. Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):783-90. doi: 10.1016/0360-3016(93)90306-g. Int J Radiat Oncol Biol Phys. 1993. PMID: 8478228 Clinical Trial.

2

Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07.

Pilepich MV, Krall JM, John MJ, Rubin P, Porter AT, Marcial VA, Martz KL. Pilepich MV, et al. Among authors: porter at. Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):813-7. doi: 10.1016/0360-3016(89)90500-2. Int J Radiat Oncol Biol Phys. 1989. PMID: 2646266 Clinical Trial.

3

Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.

Pollack A, Grignon DJ, Heydon KH, Hammond EH, Lawton CA, Mesic JB, Fu KK, Porter AT, Abrams RA, Shipley WU. Pollack A, et al. Among authors: porter at. J Clin Oncol. 2003 Apr 1;21(7):1238-48. doi: 10.1200/JCO.2003.02.025. J Clin Oncol. 2003. PMID: 12663710 Clinical Trial.

4

Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker.

Dundas GS, Porter AT, Venner PM. Dundas GS, et al. Among authors: porter at. Cancer. 1990 Jul 1;66(1):45-8. doi: 10.1002/1097-0142(19900701)66:1<45::aid-cncr2820660110>3.0.co;2-g. Cancer. 1990. PMID: 1693877

5

The role of cytoreduction prior to definitive radiotherapy in locally advanced prostate cancer--the Canadian perspective.

Porter AT, Venner PM. Porter AT, et al. Prog Clin Biol Res. 1990;359:231-7; discussion 249-50. Prog Clin Biol Res. 1990. PMID: 2284294 Review. No abstract available.

6

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.

Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Farnan N, Curran WJ Jr. Murray KJ, et al. Among authors: porter a. Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):453-9. doi: 10.1016/0360-3016(95)93160-9. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852106 Free article. Clinical Trial.

7

Postoperative radiation for cervical cancer with pathologic risk factors.

Hart K, Han I, Deppe G, Malviya V, Malone J Jr, Christensen C, Chuba P, Porter A. Hart K, et al. Among authors: porter a. Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):833-8. doi: 10.1016/s0360-3016(96)00560-3. Int J Radiat Oncol Biol Phys. 1997. PMID: 9128959

8

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.

Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD, Pilepich MV. Lawton CA, et al. Among authors: porter a. Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):931-9. doi: 10.1016/s0360-3016(97)00288-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9276357 Clinical Trial.

9

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, Sathyanarayana JR, Yakemchuk VN, Thomas GM, Erlich LE, et al. Porter AT, et al. Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):805-13. doi: 10.1016/0360-3016(93)90309-j. Int J Radiat Oncol Biol Phys. 1993. PMID: 8478230 Clinical Trial.

10

Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results.

Ben-Josef E, Porter AT, Han S, Mertens W, Chuba P, Fontana J, Hussain M. Ben-Josef E, et al. Among authors: porter at. Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):699-703. doi: 10.1016/s0360-3016(00)01375-4. Int J Radiat Oncol Biol Phys. 2001. PMID: 11172951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,824 results

Search Page

Filters